CN104177295B - 替格列汀关键中间体1-(3-甲基-1-苯基-5-吡唑基)哌嗪的制备方法 - Google Patents
替格列汀关键中间体1-(3-甲基-1-苯基-5-吡唑基)哌嗪的制备方法 Download PDFInfo
- Publication number
- CN104177295B CN104177295B CN201310196359.6A CN201310196359A CN104177295B CN 104177295 B CN104177295 B CN 104177295B CN 201310196359 A CN201310196359 A CN 201310196359A CN 104177295 B CN104177295 B CN 104177295B
- Authority
- CN
- China
- Prior art keywords
- piperazine
- lieting
- phenyl
- pyrazolyl
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310196359.6A CN104177295B (zh) | 2013-05-24 | 2013-05-24 | 替格列汀关键中间体1-(3-甲基-1-苯基-5-吡唑基)哌嗪的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310196359.6A CN104177295B (zh) | 2013-05-24 | 2013-05-24 | 替格列汀关键中间体1-(3-甲基-1-苯基-5-吡唑基)哌嗪的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104177295A CN104177295A (zh) | 2014-12-03 |
CN104177295B true CN104177295B (zh) | 2016-08-17 |
Family
ID=51958676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310196359.6A Active CN104177295B (zh) | 2013-05-24 | 2013-05-24 | 替格列汀关键中间体1-(3-甲基-1-苯基-5-吡唑基)哌嗪的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104177295B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105175337B (zh) * | 2015-09-11 | 2017-12-01 | 沧州那瑞化学科技有限公司 | 一种1‑(3‑甲基‑1‑苯基‑1h‑吡唑‑5‑基)哌嗪的制备方法 |
CN105330604A (zh) * | 2015-10-14 | 2016-02-17 | 湖南华腾制药有限公司 | 一种替格列汀关键中间体的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698495A (en) * | 1995-11-15 | 1997-12-16 | Zeneca Limited | Herbicidal substituted pyrazole compounds |
CN1441779A (zh) * | 2000-08-10 | 2003-09-10 | 三菱制药株式会社 | 脯氨酸衍生物及其医药用途 |
WO2012099915A1 (en) * | 2011-01-19 | 2012-07-26 | Hongwen Zhu | Thiazolidine derivatives and their therapeutic use |
WO2012165547A1 (ja) * | 2011-06-01 | 2012-12-06 | 田辺三菱製薬株式会社 | ピラゾール誘導体の製造方法 |
-
2013
- 2013-05-24 CN CN201310196359.6A patent/CN104177295B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698495A (en) * | 1995-11-15 | 1997-12-16 | Zeneca Limited | Herbicidal substituted pyrazole compounds |
CN1441779A (zh) * | 2000-08-10 | 2003-09-10 | 三菱制药株式会社 | 脯氨酸衍生物及其医药用途 |
WO2012099915A1 (en) * | 2011-01-19 | 2012-07-26 | Hongwen Zhu | Thiazolidine derivatives and their therapeutic use |
WO2012165547A1 (ja) * | 2011-06-01 | 2012-12-06 | 田辺三菱製薬株式会社 | ピラゾール誘導体の製造方法 |
Non-Patent Citations (3)
Title |
---|
One-pot synthesis of 5-(substituted-amino)pyrazoles;Dharmpal S. Dodd等;《Tetrahedron Letters》;20040423;第45卷(第22期);第4265页左栏第1段、右栏最后一段和流程1 * |
Solid-phase synthesis of 5-substituted amino pyrazoles;Dharmpal S. Dodd等;《Journal of Combinatorial Chemistry》;20050517;第7卷(第4期);第586页流程2 * |
Synthesis and application of a fluorous Lawesson"s reagent: Convenient chromatography-free product purification;Zoltan Kaleta等;《Organic Letters》;20060218;第8卷(第6期);第1093-1095页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104177295A (zh) | 2014-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SA08280757B1 (ar) | معضدات gpcr تشتمل على بروبوكسي بيريدين وبيوتوكسي بيريدين | |
JP5968455B2 (ja) | チエノ[3,2−d]ピリミジン−4−オン系化合物、その製造方法、医薬品組成物および用途 | |
CN100497337C (zh) | 叶酸二甲双胍及其制备方法 | |
CN103012167A (zh) | 一种盐酸氨溴索的制备方法 | |
CN106061968A (zh) | 四唑酮‑取代的二氢吡啶酮mgat2抑制剂 | |
CN104177295B (zh) | 替格列汀关键中间体1-(3-甲基-1-苯基-5-吡唑基)哌嗪的制备方法 | |
CN104119330B (zh) | 小檗碱衍生物的合成及其在制备抗肿瘤药物和协同阿霉素抗肿瘤药物组合物中的应用 | |
CN108779089A (zh) | 灰黄霉素化合物 | |
CN103145663B (zh) | (s)-2-(2,3-二氢苯并呋喃-3-基)乙酸衍生物,其制备方法及其在医药上的应用 | |
Patel et al. | 3D-QSAR studies of dipeptidyl peptidase-4 inhibitors using various alignment methods | |
CN103319399B (zh) | 阿格列汀中间体r-3-氨基哌啶双盐酸盐的制备方法 | |
CN105037325A (zh) | 阿格列汀或其药学上可接受的盐的制备方法 | |
CN107879964A (zh) | 1‑(5‑(2‑氟苯基)‑1‑3‑(3‑甲氧丙氧基)苯磺酰氯)‑1h‑吡咯‑3‑基)‑n‑甲基胺的制备方法 | |
CN107556276B (zh) | C-三芳基葡萄糖苷类化合物及其制备方法和应用 | |
CN100366625C (zh) | Fmoc-L-丙氨酸头孢唑肟酯及其制备方法和以该中间体合成头孢唑肟丙匹酯的新工艺 | |
CN107011288A (zh) | 一种阿立哌唑中间体1‑(2,3‑二氯苯基)哌嗪盐酸盐的制备方法 | |
CN112898267A (zh) | 一种苯甲酸阿格列汀的精制方法 | |
CN103012314B (zh) | 磺胺类化合物及其制备方法和应用 | |
CN112480075A (zh) | 一种琥珀酸曲格列汀的精制方法 | |
CN104140427A (zh) | 一种四氢吡唑并[1,5-a]嘧啶的制备方法 | |
CN106588909A (zh) | 一种喹啉类衍生物的制备及其在抗炎中的应用 | |
CN106220607A (zh) | 一种s‑3‑(哌啶‑2‑基)‑氮杂环丁烷‑3‑醇的合成方法 | |
CN114262319A (zh) | 一类双功能分子、其制备方法及其应用 | |
CN104860919B (zh) | 含哌啶的苯并咪唑衍生物及其制备方法和用途 | |
CN108558836A (zh) | 一类具有双重作用机制的dpp-4抑制剂及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: Xianlin University City HintCAD road in Qixia District of Nanjing City, Jiangsu Province, No. 9 210012 Applicant after: Nanjing Huawe Medical Science & Technology Development Co., Ltd. Address before: Huawei Technology Building No. 8 road in Yuhuatai District of Nanjing City, 210012 flora in Jiangsu Province Applicant before: Nanjing Huawe Medical Science & Technology Development Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Xianlin University City HintCAD road in Qixia District of Nanjing City, Jiangsu Province, No. 9 210012 Patentee after: Nanjing Huawei Medicine Technology Group Co Ltd Address before: Xianlin University City HintCAD road in Qixia District of Nanjing City, Jiangsu Province, No. 9 210012 Patentee before: Nanjing Huawe Medical Science & Technology Development Co., Ltd. |